Found 423 matching trials
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM) PHASE1 This multicenter, open-label, Phase I study will evaluate the safety, effic...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma PHASE1 The purpose of this study is to evaluate the safety and efficacy of Bendamu...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial
High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma PHASE2 A prospective pilot trial was proposed to patients with DLBCL, with IH or h...
Show More Location
University Hospital
Learn More & Join Trial
Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant PHASE1 This phase I trial studies the best dose and how well bendamustine works wi...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Autologous Hematopoietic Stem Cell Transplantation for Neurological Damage Associated With Hereditary Homocysteine Remethylation Disorders NA This study aims to evaluate the safety, feasibility, and preliminary effica...
Show More Location
Institute of Hematology & Blood Diseases Hospital, China
Learn More & Join Trial
Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to ASCT PHASE2 Multicentric phase II trial to evaluate efficacy and safety of ibrutinib in...
Show More Location
Hospital Universitario Son Espases
Learn More & Join Trial
Fecal Microbiota Transplantation in aGvHD After ASCT PHASE3 Acute graft-versus-host-disease (aGvHD) is a typical complication after all...
Show More Location
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz
Learn More & Join Trial
Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients PHASE3 Multiple myeloma is a malignant incurable hematological disease where survi...
Show More Location
Hæmatologisk afdeling B, Aalborg Sygehus Syd
Learn More & Join Trial
Autologous Hematopoietic Stem Cell Transplantation for Refractory Autoimmune Diseases PHASE1 While glucocorticoids and immunosuppressants ameliorate manifestations of a...
Show More Location
Charité Universitätsmedizin Berlin
Learn More & Join Trial
Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma PHASE2 Patients included in the study will receive induction treatment during 6 mo...
Show More Status
Active Not Recruiting
Location
Hospital Clínic de Barcelona
Learn More & Join Trial